With Covid-19 cases rising on a daily basis, pharmaceutical companies levelled up the production of their medical supplies in order to meet the demands of the people
Since the outbreak of the pandemic, the availability and delivery of large quantities of medical products have been an essential need. Although the production of supplies increased significantly to help curb the critical situation, what remained a challenge was the distribution of these supplies to the right customers in a time-efficient manner. Despite the fact that a crisis was being dealt with, the positive part was that the supply chain sector advanced itself with the adoption of solutions that would increase the efficiency of the delivery process.
The latest supply chain solutions that were adopted ensured full visibility, safety, and tamper-proof distribution of the medical products, despite the complexities of their transportation. These solutions were adopted by leading manufacturers and distributors of pharmaceutical products such as Biotech Pharma Services and were used to benefit millions of people around the globe.
Cloud-based networks for efficient distribution
Biotech Pharma is one of the leading distributors of premium pharmaceutical products in the Middle East and has over a decade of experience in the medical industry. It is specialized in patent licensing, product creation, regulatory relations, distribution, product launch, contracting, and commercialization.
Huthaifa Salem, General Manager, Biotech Pharma Services emphasised, “As the pandemic continued and increased the need for efficient delivery of pharmaceutical supplies, Biotech Pharma adopted cloud-based networks as part of its supply chain systems in order to maintain up-to-date and end-to-end supply chain visibility to deliver the desired product to the consumer within 24 to 48 hours. That’s why, we have managed to achieve a sales growth of 48 per cent.”
Cost-effective marketing solutions
Biotech Pharma goes far beyond dealing with only pharmaceutical products and facilities, and also focuses on the development and execution of detailed sales and marketing plans for each brand it works with. Moreover, it also takes care of marketing authorization applications for human health, herbal, and pharmaceutical products, as well as regulatory aspects of production sites and marketing authorization holders, through its multidisciplinary team of regulatory affairs experts. The company’s regulatory affairs team helps its clients in determining the quickest and most cost-effective path to market their products, and also provides resources for the life cycle management of these
Salem clarified, “When it comes to creating a customized regulatory strategy for pharmaceutical products, we are a one-stop-shop for our clients, guiding them through the licensing process by helping them get through hurdles and authority interactions.” Once the registration process is completed, Biotech Pharma’s Regulatory Affairs team assists its customers in the life cycle management of variations, line additions, renewals, PSUR applications, and responses to authority demands for their products, all while maintaining compliance with regulatory standards.
He concluded, “We will pursue our commitment to the provision of the highest quality of Health and Medical Services for our customers in the GCC as we aim to maintain our outstanding quality of support and services for our principal companies. Our key concern and support are given to our staff, who are our true backbone in reinforcing our success.”